Intra Cellular Therapies Analysis

Intra Stock Analysis Notes

About 96.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.73. Intra Cellular Therapies had not issued any dividends in recent years. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people. To learn more about Intra Cellular Therapies call Sharon Mates at 646 440 9333 or check out https://www.intracellulartherapies.com.

Intra Cellular Therapies Investment Alerts

Intra Cellular Therapies Upcoming and Recent Events

Intra Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 14.05 B.

Intra Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.15) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.15.

Intra Cellular Therapies Insider Trading Activities

Intra Cellular Outstanding Bonds

Intra Cellular Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Intra Cellular prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intra shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Intra Cellular. By using and applying Intra Stock analysis, traders can create a robust methodology for identifying Intra entry and exit points for their positions.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

If you are still planning to invest in Intra Cellular Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intra Cellular's history and understand the potential risks before investing.